Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
06/22/2011 | CN102100808A Chinese medicinal preparation for treating headache |
06/22/2011 | CN102100799A Anodynia disinfecting alcohol for injection |
06/22/2011 | CN102100774A Green and natural Chinese medicine powder for foot bath and health care |
06/22/2011 | CN102100768A Preparation technique for ephedra decoction in novel formed formulation and production method thereof |
06/22/2011 | CN102100765A Processing technique of peach kernels |
06/22/2011 | CN102100763A Preparation technology of new integrative formulation of counterflow decoction and production method thereof |
06/22/2011 | CN102100758A Qingpeng gel for relieving pain and subdhing swelling and preparation method thereof |
06/22/2011 | CN102100757A Qingpeng spray preparation for relieving pain and swelling and preparation method thereof |
06/22/2011 | CN102100755A Preparation technology of integrated ephedra, aconite and asarum decoction novel dosage form |
06/22/2011 | CN102100720A Ainsliaea fragrans champ caffeoylquinic acid extracts and preparation and application thereof |
06/22/2011 | CN102100714A Method for extracting active ingredients of Echinacea through supercritical carbon dioxide |
06/22/2011 | CN102100712A Method for extracting panax notoginseng saponins by using continuous countercurrent ultrasonic extraction combined film technology |
06/22/2011 | CN102100707A Cordyceps sinensis health-care liquor |
06/22/2011 | CN102100696A Bone joint maintenance composite containing dimethyl sulfone |
06/22/2011 | CN102100686A Medicinal composition containing ibuprofen and arginine and preparation method and application thereof |
06/22/2011 | CN102100679A Carprofen matrix tablets |
06/22/2011 | CN102100459A Chinese herbal medicine bamboo charcoal healthcare mattress and preparation method thereof |
06/22/2011 | CN101716304B Liquid for decreasing swelling, dredging channels and activating collaterals |
06/22/2011 | CN101683517B Plaster for treating neck-shoulder-waist-leg pain and method of preparing same |
06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
06/22/2011 | CN101575333B Quinazoline derivatives and medical application thereof |
06/22/2011 | CN101570512B Curcumin substituted pyrazole derivatives, and preparation method and uses thereof |
06/22/2011 | CN101569682B Medical composition for treating rheumatoid arthritis and preparation method |
06/22/2011 | CN101564424B Common lamiophlomis root chewable tablet and preparation thereof |
06/22/2011 | CN101485728B Chrysanthemum medicine pillow |
06/22/2011 | CN101293905B Benzoxazole ketone glycoside compounds and preparation method thereof |
06/22/2011 | CN101167787B Albizzia plant extraction composition for inhibiting angiogenesis and preparation and application thereof |
06/22/2011 | CN101031569B Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
06/21/2011 | US7964732 Substituted bicyclocarboxyamide compounds |
06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
06/21/2011 | US7964644 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means |
06/21/2011 | US7964592 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
06/21/2011 | US7964220 Method for treating a mammal by administration of a compound having the ability to release CO |
06/21/2011 | US7964199 Therapeutic composition comprising a botulinum neurotoxin |
06/21/2011 | CA2495386C Protein kinase inhibitors and uses thereof |
06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
06/21/2011 | CA2472188C Polymeric gel system for the controlled delivery of codrugs |
06/21/2011 | CA2462537C Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
06/21/2011 | CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon |
06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
06/16/2011 | WO2011072265A1 Aminoacyl trna synthetases for modulating inflammation |
06/16/2011 | WO2011071996A1 Faah inhibitors |
06/16/2011 | WO2011071970A2 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt) |
06/16/2011 | WO2011071716A1 Heterocyclic compounds containing an indole core |
06/16/2011 | WO2011071296A2 Anti-inflammatory pharmaceutical composition comprising extracts from broussonetia papyrifera and lonicera japonica |
06/16/2011 | WO2011071039A1 Identification of hla-dr4 epitope and use for treatment of arthritis |
06/16/2011 | WO2011070415A1 Novel therapeutic methods for treating inflammation and immune system disorders |
06/16/2011 | WO2011070030A1 Heterocyclic sulfonamide derivatives |
06/16/2011 | WO2011047770A3 Pyrazolopyrimidine derivatives |
06/16/2011 | WO2011031476A3 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation |
06/16/2011 | WO2011024146A3 Adam12 inhibitors and their use against inflammation-induced fibrosis |
06/16/2011 | WO2011020095A3 Compositions and methods of treating inflammation |
06/16/2011 | WO2011017346A3 Fast-acting naproxen composition with reduced gastrointestinal effects |
06/16/2011 | US20110145941 Antibodies and derivatives thereof |
06/16/2011 | US20110144330 2,4-Pyrimidinediamine Compounds and their Uses |
06/16/2011 | US20110144320 N-pyrazole a2a receptor agonists |
06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
06/16/2011 | US20110144212 Key intermediate for the preparation of stilbenes, solid forms of pterostilbene, and methods for making the same |
06/16/2011 | US20110144207 Aryl alkyl carboxylic acid salts, process for preparation and dosage forms |
06/16/2011 | US20110144183 Oligonucleotides for treating inflammation and neoplastic cell proliferation |
06/16/2011 | US20110144164 Pyridone derivatives as NK3 antagonists |
06/16/2011 | US20110144158 Isoindole-imide compounds and compositions comprising and methods of using the same |
06/16/2011 | US20110144157 Pyrrole derivatives, preparation of same and therapeutic application thereof |
06/16/2011 | US20110144145 Methods for treating visceral fat conditions |
06/16/2011 | US20110144144 Ibuprofen and narcotic analgesic compositions |
06/16/2011 | US20110144143 pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
06/16/2011 | US20110144140 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
06/16/2011 | US20110144136 Novel adenine derivatives |
06/16/2011 | US20110144134 Anti-Inflammatory Pyrazolopyrimndines |
06/16/2011 | US20110144130 Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl-penta-2,4-dienoic acid as a cosmetic |
06/16/2011 | US20110144122 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
06/16/2011 | US20110144120 Phenyl-alkyl piperazines having tnf-modulating activity, preparation method, and therapeutic use thereof |
06/16/2011 | US20110144119 Oxazole derivatives useful as inhibitors of faah |
06/16/2011 | US20110144115 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
06/16/2011 | US20110144113 Triazolotriazines as kinase inhibitors |
06/16/2011 | US20110144110 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
06/16/2011 | US20110144104 Pyrrolidinyl-alkyl-amide derivatives, their preparation, and their therapeutic application as ccr3 receptor ligands |
06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
06/16/2011 | US20110144100 Triazolopyridine compounds as pim kinase inhibitors |
06/16/2011 | US20110144097 2-amino-5,5-difluoro-5,6-dihydro-4h-[1,3]oxazin-4-yl)-phenyl]-amides |
06/16/2011 | US20110144085 Triazolopyridine compounds as pim kinase inhibitors |
06/16/2011 | US20110144076 Preterm delivery diagnostic assay |
06/16/2011 | US20110144075 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
06/16/2011 | US20110144073 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
06/16/2011 | US20110144070 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
06/16/2011 | US20110144057 Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereof |
06/16/2011 | US20110144056 Pyrazole derivatives useful as inhibitors of faah |
06/16/2011 | US20110144055 Health Care |
06/16/2011 | US20110144040 Acteoside and acteoside-rich plant extracts for increasing athletic performance in humans |
06/16/2011 | US20110144039 Antioxidative and hepatoprotective compositions containing diaryheptanoids from alnus japonica |
06/16/2011 | US20110144021 Therapeutic proteins from latex |
06/16/2011 | US20110144018 Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy |
06/16/2011 | US20110144011 Cellular Activation Insulin Therapy |
06/16/2011 | US20110144002 Use of AMPs for Treatment of UTI/Cystitis |
06/16/2011 | US20110144001 Highly bridged peptides from actinomadura namibiensis |